Harvard’s modified herpes virus can’t multiply or infect cells. Two important genes are deleted to take the bite out of herpes. Scientists hope that this vaccine will prepare the body should it be attacked by the real virus. It may also help symptomatic people already carrying herpes. Acambis are investigating the technology, and Harvard continues to research the treatment. You can donate to their research here.